Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning.
Animals
Binding Sites
CHO Cells
Carbamates
/ chemistry
Cricetulus
Dopamine Agonists
/ chemistry
Dopamine Antagonists
/ chemistry
Drug Design
Humans
Ligands
Machine Learning
Molecular Docking Simulation
Molecular Dynamics Simulation
Piperazines
/ chemistry
Protein Conformation
Receptors, Dopamine D3
/ chemistry
Salicylamides
/ metabolism
Dopamine D3 receptor
Drug design
GPCR
MTDL
Machine learning
Molecular dynamics
Molecular recognition
Mutil-target
Polypharmacology
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
15 Feb 2020
15 Feb 2020
Historique:
received:
05
06
2019
revised:
02
12
2019
accepted:
16
12
2019
pubmed:
16
1
2020
medline:
18
2
2020
entrez:
16
1
2020
Statut:
ppublish
Résumé
Local changes in the structure of G-protein coupled receptors (GPCR) binders largely affect their pharmacological profile. While the sought efficacy can be empirically obtained by introducing local modifications, the underlining structural explanation can remain elusive. Here, molecular dynamics (MD) simulations of the eticlopride-bound inactive state of the Dopamine D3 Receptor (D3DR) have been clustered using a machine learning-based approach in the attempt to rationalize the efficacy change in four congeneric modulators. Accumulating extended MD trajectories of receptor-ligand complexes, we observed how the increase in ligand flexibility progressively destabilized the crystal structure of the inactivated receptor. To prospectively validate this model, a partial agonist was rationally designed based on structural insights and computational modeling, and eventually synthesized and tested. Results turned out to be in line with the predictions. This case study suggests that the investigation of ligand flexibility in the framework of extended MD simulations can assist and inform drug design strategies, highlighting its potential role as a powerful in silico counterpart to functional assays.
Identifiants
pubmed: 31940507
pii: S0223-5234(19)31127-4
doi: 10.1016/j.ejmech.2019.111975
pii:
doi:
Substances chimiques
Carbamates
0
Dopamine Agonists
0
Dopamine Antagonists
0
Ligands
0
Piperazines
0
Receptors, Dopamine D3
0
Salicylamides
0
eticlopride
J8M468HBH4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111975Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.